Clinical Trial

Impact of the Microbiota on the Likelihood of Renal Graft Rejection

Study acronym: MERRLIN
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Identification of a bacterial signature in the blood or stool that may be associated with acute rejection in patients treated with Nulojix during their first year of transplant.
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-08-04
notable Primary completion moved earlier: 2027-01-07 -> 2025-04-08 2026-08-04
minor Completion moved earlier: 2027-01-07 -> 2026-10-09 2026-08-04
Trial Details
NCT Number NCT04736381
Lead Sponsor Institut National de la Santé Et de la Recherche Médicale, France
Conditions Kidney Transplant Rejection
Enrollment 70 participants
Start Date 2021-10-07
Primary Completion 2025-04-08 (estimated)
Study Completion 2026-10-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-03